New Mouse Model for Mesothelioma Drug Testing
Mesothelioma is among the most challenging cancers to treat. Increasingly, doctors are taking a multi-modal approach to treatment including surgery and some combination of adjuvant therapies such as chemotherapy, radiation or other, newer modalities. But it has always been difficult to test the effectiveness of these mesothelioma therapies in the lab since they depend on the test subject having had surgery first.
Now, a group of researchers at Brigham and Women's Hospital in Boston have come up with a more reliable way to conduct these tests. By grafting human malignant mesothelioma cells into the peritoneal cavities of laboratory mice, the researchers were able to simulate mesothelioma. The mesothelioma cells were allowed to take hold for 14 days, after which time the tumors were surgically removed via laparotomy. The result was a murine (mouse) model capable of testing various kinds of adjuvant mesothelioma therapies.
"Cytoreductive surgery in mice was feasible and reproducible, and incurred less than 5% operative mortality," write the researchers in a summary of their experiment for the Annals of Thoracic Surgery.
After creating this murine model, the researchers used it to test a potential new therapy for mesothelioma. Before they closed the surgical wounds of the test mice, researchers treated the cavity with 10 mg of the chemotherapy drug paclitaxel loaded onto tiny, expandable nanoparticles. The nanoparticles are designed to seek out and deliver the paclitaxel into any mesothelioma cells left behind after surgery. Morbidity and survival of the mice were assessed over the next 90 days.
There are many alternative mesothelioma treatments which are being used now like acupuncture, homeopathy, herbs, massages and many more. There are also combination of treatments being used like surgery, radiation therapy, and chemotherapy, called multimodality therapy. Apart from this, heated intra-operative intraperitoneal chemotherapy and use of pemetrexed drug like Alimta are also being used.
Although the cytoreductive surgery alone did nothing to improve survival rates, the addition of paclitaxel via the nanoparticles "significantly increased survival" compared with the untreated mice. The testers concluded that the drug "merits further evaluation for intracavitary drug delivery following the surgical resection of malignant mesothelioma." The murine model created by the Brigham & Women's team opens the door for more effective testing of other perioperative therapies for mesothelioma.
Questions and Answers
Article Tags:
mesothelioma
Mesothelioma, cancer of the mesothelium, is a rare cancer taking too many lives today.
Mesothelioma is one of the rarest forms of cancer and it originates in mesothelium.
Mesothelioma lawyers are available to discuss the potential compensation for mesothelioma cases.
Diagnosis of mesothelioma can change the entire life of patients and their families in a moment. A cure for mesothelioma has not yet been discovered.
Mesothelioma is a serious disease that is caused by exposure to asbestos and a very rare form of cancer.
The deadliest and most dreaded disease of all, in the present day, is Cancer. Sadly, Cancer has been taking its toll for many ages.
Cancer translational research brings together scientists' and clinicians' suggestions to develop solutions to biomedical complications. This kind of applied research strives to offer strategies to questions surrounding the etiology, pathology, diagnosis, prevention and treating cancer.
Orbs are actually a lumpectomy or quadrantectomy combined with rotating the breast tissue or mobilize the flap into the cavity of the surgery time fill is removed. It also includes the comparative change in shape and size is doing in relation to breast and moved if necessary, does not affect the conversion of the breast. The deferred plan the reconstruction is not part of endoplasmic techniques. Both procedures are performed by specific thoracic surgeons.
What every woman fears for is losing her self confidence , losing hope and losing her personality. The term "Breast Cancer" is a very negative word and that it creates negative vibrations in her heart. So, to make her comfortable with the basics of breast cancer and to make her means any woman understand that this type of cancer is the least dangerous than all cancers and that if it is detected early then you will fight with it successfully. Causes, Symptoms, treatment, discussed in detail.
Mesothelioma is a rare cancer that originates in the mesothelium. The mesothelium is the protective lining that covers the body's internal organs. Mesothelioma occurs when the mesothelium cells start to divide uncontrollably.
Chemotherapy is a treatment for killing cancerous cells which is given intravenous or extra-venous to the cancer patient. Even breast cancer patients have to go through the treatment. This treatment mainly focuses on the cancerous cells that are spread in the blood stream in the whole body . If any cancerous cells are there then they are killed by the chemotherapy medicine. The medicine is very costly and it has to be taken for one or two days continuously for every 21 days .
Asbestos fibers are microscopic, though they are also quite durable. For this reason, asbestos was used in a number of different industrial compounds to enhance strength and resistance to temperature extremes- two properties at which the mineral is highly adept.
It has long been known that smoking is hazardous to one's health, causing a marked increase in instances of mesothelioma lung cancer among those who smoke regularly.
Exposure to asbestos particles is one of the principal causes of mesothelioma cancer, also known as asbestos cancer. As a naturally occurring mineral with useful commercial applications, asbestos is found in plumbing, insulation and other building materials and products.
There are several risk factors that increase the likelihood that a person will develop mesothelioma.
Mesothelioma Information – Basics Mesothelioma is a type of cancer that is usually caused by previous exposure to asbestos.
